Segmed Appoints David Gascoigne as CEO in Leadership Transition
Co-Founder Dr. Martin Willemink moves to Chief Scientific Officer role; Dr. Yin Ho joins Board of Directors as part of...
Pharmaceutical
Ubie and CMI Media Group Partner to Modernize DTC Advertising with Highly Personalized Consumer Campaigns in Women’s Health, Hematology
There is a critical need for trustworthy, hyper-personalized information earlier in the diagnosis and treatment journey to empower patients to...
CEFALY to Demonstrate Its Migraine Treatment Device at the American College of Obstetricians and Gynecologists’ Annual Clinical & Scientific Meeting
DARIEN, Conn., May 13, 2025 /PRNewswire/ -- Medical device maker CEFALY Technology will be conducting live demonstrations of its clinically...
Hyperion Biosystems and Colorcon Enter into Licensing Agreement to Commercialize Novel On-Dose Authentication Technology for Pharmaceutical and Nutraceutical Industries
This unique on-dose authentication solution combines Hyperion Biosystems' portfolio of physics-based algorithms and AI-enhanced vision systems with Colorcon's custom taggants to...
Connect Biopharma Initiates Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma
– Expect to report topline data from the Seabreeze STAT Asthma study in 1H 2026 – – On track to...
General Oncology to Participate in Three Upcoming Conferences
BOSTON, May 13, 2025 (GLOBE NEWSWIRE) -- General Oncology, Inc., a clinical-stage biopharmaceutical company dedicated to pioneering first-in-class treatments for...
Capricor Therapeutics Appoints Michael Binks, M.D. as Chief Medical Officer
— Dr. Binks joins Capricor in anticipation of potential approval of deramiocel in Q3 2025, bringing extensive experience in neuromuscular...
HCW Biologics Announces Positive Results of Studies of Proprietary Compound, HCW9206 and Availability for Commercialization
Addresses key challenges for CAR-T therapies Potential to significantly reduce costs and improve clinical efficacy of engineered effector T cells...
Adial Pharmaceuticals Receives Milestone Payment from Adovate Following Initiation of Phase 1 Study
Milestone Achieved as Adovate Initiates First-in-Human Study for Novel Asthma Therapy Targeting Underserved, Multi-Billion Dollar MarketGlen Allen, Va., May 13,...
Bright Minds Biosciences Announces Positive Findings from its DBA/2 Mouse Model Study Evaluating BMB-101
- BMB-101 demonstrated a complete elimination of drop attacks in the DBA/2 mouse model - - The DBA/2 model is...
Affimed Announces Filing for the Opening of Insolvency Proceedings
MANNHEIM, Germany, May 13, 2025 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients...
VivoSim’s NAMKind™ Intestine Wins Blue Ribbon Award at Digestive Disease Week Conference
SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”) announced today that...
Candel Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
Announced accepted oral presentation of positive phase 3 randomized placebo controlled clinical trial results of CAN-2409 (aglatimagene besadenovec) in localized...
Reflect Scientific Secures Patents for Data Center Cooling with Cryogenic Innovation
OREM, Utah, May 13, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a leader in cryogenic technology, today announced...
CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates
- Updated BOND-003 clinical results presented at AUA showing best-in-disease durability and tolerability data for Cohort C with 24-month complete...
Remedy Plan Therapeutics Raises $18 Million Financing to Accelerate Advancement of Lead Asset RPT1G into Phase 1/2 Trials
Financing includes participation from Schooner Capital, Alexandria Venture Investments, and other existing investorsInvestment accelerates advancement of RPT1G, a novel NAMPT...
Werewolf Therapeutics to Participate in Hanson Wade’s 6th Annual Cytokine-Based Drug Development Summit
WATERTOWN, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical...
Fangzhou CEO Honored at 2025 VBEF Conference as Company Showcases AI Medical Innovations
SUZHOU, China, May 13, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, participated...
Elpis Biopharmaceuticals to Present New Data on Multi-Mechanism Armored CAR-T Therapy at PEGS Summit 2025
Proprietary cytokine-engineered CAR-T therapy shows durable anti-tumor activity and low-dose efficacy in solid tumors LEXINGTON, Mass. and SINGAPORE, May 12,...
$101M XPRIZE HEALTHSPAN AWARDS FIRST MILESTONE WINNERS DRIVING TOWARD REVOLUTIONARY HEALTHY AGING ADVANCES
Over 600 competing teams from 58 countries entered global competition. Teams with a broad range of potential solutions for healthspan...